Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,02119,040 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2025

Abstract Unexpected findings, or incidentalomas, are increasing dramatically with the growth in the use of imaging technology within healthcare organizations. Incidentalomas may in...

$6.74M
USD
Completed NON-SBIR/STTR RPGS
MULTIPLEXED ISOFORM QUANTIFICATION IN HER2-POSITIVE BREAST CANCER
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2026

While targeted therapy increases overall survival rates in HER2-positive breast cancer patients, most patients will experience recurrence due to resistance to initially successful...

$3.39M
USD
Completed NON-SBIR/STTR RPGS
Dihydroceramide desaturase (DES1) as a mediator of receptor tyrosine kinase-driven metastasis in breast cancer
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2026

ABSTRACT Despite improvements in treatment, clinical outcomes for late stage breast cancer (BC) remain poor and there is a critical need for new therapies for metastatic disease. H...

$3.44M
USD
Completed NON-SBIR/STTR RPGS
A community-based trial of a voluntary smoke-free home intervention in permanent supportive housing for formerly homeless adults
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY The focus of this proposal is on expanding access to voluntary smoke-free homes to formerly homeless residents residing in permanent supportive housing, and examini...

$6.36M
USD
Completed NON-SBIR/STTR RPGS
MULTIPLEXED ISOFORM QUANTIFICATION IN HER2-POSITIVE BREAST CANCER
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2025

While targeted therapy increases overall survival rates in HER2-positive breast cancer patients, most patients will experience recurrence due to resistance to initially successful...

$3.67M
USD
Completed NON-SBIR/STTR RPGS
A community-based trial of a voluntary smoke-free home intervention in permanent supportive housing for formerly homeless adults
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY The focus of this proposal is on expanding access to voluntary smoke-free homes to formerly homeless residents residing in permanent supportive housing, and examini...

$6.7M
USD
Completed NON-SBIR/STTR RPGS
Development of A HTLV-1 Vaccine
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2021 – 2026

PROJECT SUMMARY For this proposal we intend to develop a novel vaccine to prevent and possibly treat Human T cell leukemia virus type-1 (HTLV-1) associated diseases. HTLV-1 is a hu...

$5.61M
USD
Completed NON SBIR/STTR CONTRACTS
SEER CORE INFRASTRUCTURE SUPPORT
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2021

The purpose of the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER) Program is to assemble and report annual estimates of cancer statistics that per...

$13.39M
USD
Completed NON SBIR/STTR CONTRACTS
SEER CORE INFRASTRUCTURE SUPPORT
NATIONAL CANCER INSTITUTE Illinois State Dept of Public Health United States 2021 – 2021

The purpose of the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER) Program is to assemble and report annual estimates of cancer statistics that per...

$13.9M
USD
Completed OTHER RESEARCH-RELATED
Single cell quantification of genomic instability in cancer as a determinant of therapeutic response
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2024

PROJECT ABSTRACT Tumor genetic heterogeneity is an extensive feature of cancer biology and underlies patient response to therapy. One aspect of tumor heterogeneity that has been di...

$998K
USD
Completed NON-SBIR/STTR RPGS
MULTIPLEXED ISOFORM QUANTIFICATION IN HER2-POSITIVE BREAST CANCER
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2025

While targeted therapy increases overall survival rates in HER2-positive breast cancer patients, most patients will experience recurrence due to resistance to initially successful...

$3.45M
USD
Completed NON-SBIR/STTR RPGS
Multimodal iterative sequencing of cancer genomes and single tumor cells
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2025

ABSTRACT Genome  sequencing  technology  has  been  transformative  in  the  analysis  of  cancer.    From  genomic, transcriptomic, and epigenetic data, researchers are making new...

$3.71M
USD
Completed NON-SBIR/STTR RPGS
Dihydroceramide desaturase (DES1) as a mediator of receptor tyrosine kinase-driven metastasis in breast cancer
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2026

ABSTRACT Despite improvements in treatment, clinical outcomes for late stage breast cancer (BC) remain poor and there is a critical need for new therapies for metastatic disease. H...

$3.55M
USD
Completed NON-SBIR/STTR RPGS
Development of A HTLV-1 Vaccine
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2021 – 2026

PROJECT SUMMARY For this proposal we intend to develop a novel vaccine to prevent and possibly treat Human T cell leukemia virus type-1 (HTLV-1) associated diseases. HTLV-1 is a hu...

$5.84M
USD
Completed NON-SBIR/STTR RPGS
MULTIPLEXED ISOFORM QUANTIFICATION IN HER2-POSITIVE BREAST CANCER
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2025

While targeted therapy increases overall survival rates in HER2-positive breast cancer patients, most patients will experience recurrence due to resistance to initially successful...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML
NATIONAL CANCER INSTITUTE Coriell Institute for Medical Research United States 2021 – 2026

Explore the signaling mechanisms of acquired resistance to tyrosine kinase inhibitors in AML Abstract Acute myeloid leukemia (AML) is a malignant hematopoietic disease and the most...

$4M
USD
Completed NON-SBIR/STTR RPGS
Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2025

Abstract Unexpected findings, or incidentalomas, are increasing dramatically with the growth in the use of imaging technology within healthcare organizations. Incidentalomas may in...

$6.43M
USD
Completed NON-SBIR/STTR RPGS
A community-based trial of a voluntary smoke-free home intervention in permanent supportive housing for formerly homeless adults
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY The focus of this proposal is on expanding access to voluntary smoke-free homes to formerly homeless residents residing in permanent supportive housing, and examini...

$6.57M
USD
Completed NON SBIR/STTR CONTRACTS
SEER CORE INFRASTRUCTURE SUPPORT
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2024

The purpose of the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER) Program is to assemble and report annual estimates of cancer statistics that per...

$12.4M
USD
Completed NON SBIR/STTR CONTRACTS
SEER CORE INFRASTRUCTURE SUPPORT
NATIONAL CANCER INSTITUTE Illinois State Dept of Public Health United States 2021 – 2024

The purpose of the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER) Program is to assemble and report annual estimates of cancer statistics that per...

$13.94M
USD